Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cue Health stock

Learn how to easily invest in Cue Health stock.

Cue Health, maker of COVID-19 tests, completed its initial public offering at $16 per share, right in the middle of its pricing expectations. The IPO raised $200 million for the company and gives it a valuation of $2.3 billion.

HLTH will debut on the Nasdaq later today, but shares are available for limit orders on Robinhood and other platforms.

How to buy shares in Cue Health

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HLTH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Cue Health stock price (NASDAQ: HLTH)

Use our graph to track the performance of HLTH stocks over time.

Cue Health shares at a glance

Information last updated 2022-09-21.
Latest market close$2.93
52-week range$2.75 - $22.55
50-day moving average $3.65
200-day moving average $6.70
Wall St. target price$8.25
PE ratio 15.5714
Dividend yield $0 (0%)
Earnings per share (TTM) $0.21

Buy Cue Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cue Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cue Health price performance over time

Historical closes compared with the close of $2.93 from 2022-09-26

1 week (2022-09-20) -10.40%
1 month (2022-08-26) -17.23%
3 months (2022-06-28) -14.33%
6 months (2022-03-28) -56.53%
1 year (2021-09-28) -80.70%
2 years (2020-09-24) N/A
3 years (2019-09-24) N/A
5 years (2017-09-24) N/A

Is Cue Health stock undervalued or overvalued?

Valuing Cue Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cue Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cue Health's P/E ratio

Cue Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Cue Health shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Cue Health's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.

Cue Health's EBITDA

Cue Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $50.9 million.

The EBITDA is a measure of a Cue Health's overall financial performance and is widely used to measure a its profitability.

To put Cue Health's EBITDA into context you can compare it against that of similar companies.

Cue Health financials

Revenue TTM $683.3 million
Operating margin TTM 1.91%
Gross profit TTM $298.7 million
Return on assets TTM 1.05%
Return on equity TTM -11.3%
Profit margin -6.25%
Book value $4.33
Market capitalisation $484.5 million

TTM: trailing 12 months

Cue Health share dividends

We're not expecting Cue Health to pay a dividend over the next 12 months.

You may also wish to consider:

Cue Health overview

Cue Health Inc. , a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Frequently asked questions

What percentage of Cue Health is owned by insiders or institutions?
Currently 15.238% of Cue Health shares are held by insiders and 48.664% by institutions.
How many people work for Cue Health?
Latest data suggests 1,585 work at Cue Health.
When does the fiscal year end for Cue Health?
Cue Health's fiscal year ends in December.
Where is Cue Health based?
Cue Health's address is: 4980 Carroll Canyon Road, San Diego, CA, United States, 92121
What is Cue Health's ISIN number?
Cue Health's international securities identification number is: US2297901009

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site